NCT07100106 · Interventional trial
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Breast Cancer
Delaware Valley sites
- University of Pennsylvania - Abramson Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory